Industry Roundup: Keep Extra-Strength Acetaminophen OTC – McNeil-Backed Survey
This article was originally published in The Tan Sheet
Executive Summary
Keep extra-strength acetaminophen OTC – McNeil-backed survey; direct sellers Jenuesse, MonaVie combine; Four Elements makes drug claims; and more news in brief.
You may also be interested in...
In Brief
Lane Labs in contempt, judge says; NAD delineates between “entire” and “100%”; ERSP eyes stem cell claims; Probiotics lift Schiff brands; more news In Brief.
McNeil Proposes Tylenol Label Change To Keep 1,000-MG Dose Available OTC
In a bid to keep 500-mg tablets and 1,000-mg doses of acetaminophen available over the counter, McNeil Consumer Healthcare argues revised dosing instructions would address the root cause of unintentional overdose without unduly restricting access to the popular painkiller
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.